APIs Psychedelics
Benuvia manufactures GMP APIs and develops new chemical entities. Our psychedelic APIs, are produced under strict quality standards to ensure purity and consistency and are designed to support cutting-edge research and therapeutic applications.
Psilocybin
Psilocybin is a naturally occurring psychedelic compound found in certain species of mushrooms. It is converted into psilocin in the body, which has psychoactive properties. Psilocybin primarily acts on serotonin receptors, particularly 5-HT2A, leading to altered perception and cognition. It is being studied for its potential to treat depression, anxiety, and PTSD, demonstrating promising results in clinical trials. Psilocybin is produced under GMP conditions, suitable for FDA-regulated clinical trials, and is synthetically produced and available as GLP material suitable for preclinical toxicology studies or as non-GMP research grade material.
- IUPAC Chemical Name:
[3-(2- Dimethylaminoethyl)-1H-indol-4-yl] dihydrogen phosphate - Common Synonyms:
Psilocybin, 4-Phosphoryloxy-N,N-dimethyltryptamine - CAS Number: 520-52-5
- DEA Schedule: Schedule I
- Controlled Substances Code Number (CSCN): 7437
Psilocybin Fumarate
Psilocin is the active metabolite of psilocybin, responsible for its psychoactive effects. It primarily acts as a partial agonist at serotonin receptors, particularly 5-HT2A, 5-HT2C, and 5-HT1A, contributing to its hallucinogenic properties. Psilocin is being investigated for therapeutic applications in treating mental health conditions such as depression and anxiety. It is produced in compliance with GMP for FDA-regulated trials and is synthetically produced and available as GLP material suitable for preclinical toxicology studies or as non-GMP research grade material.
- IUPAC Chemical Name:
3-[2(Dimethylamino)ethyl]-1H-indol-4-ol - Common Synonyms:
Psilocin, 4-Hydroxy-N,N-dimethyltryptamine - CAS Number: 520-53-6
- DEA Schedule: Schedule I
- Controlled Substances Code Number (CSCN): 7348
DMT Fumarate
N,N-Dimethyltryptamine (DMT) is a naturally occurring psychedelic compound found in various plants and animals. It is known for its powerful and short-lasting psychoactive effects. DMT primarily acts on serotonin receptors, particularly 5-HT2A, leading to intense visual and auditory hallucinations. It is being studied for its potential therapeutic applications in treating conditions like depression and PTSD. DMT is produced under GMP conditions, suitable for FDA-regulated clinical trials, and is synthetically produced and available as GLP material suitable for preclinical toxicology studies or as non-GMP research grade material.
- IUPAC Chemical Name:
2-(1H-Indol-3-yl)-N,N-dimethylethanamine - Common Synonyms:
DMT, N,N-Dimethyltryptamine, Dimitri - CAS Number: 61-50-7
- DEA Schedule: Schedule I
- Controlled Substances Code Number (CSCN): 7435
5-MeO-DMT Succinate
5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) is a naturally occurring psychedelic compound found in various plants and the venom of certain toads. It is known for its intense and short-lasting psychoactive effects. 5-MeO-DMT acts on serotonin receptors, particularly 5-HT1A and 5-HT2A, contributing to its powerful hallucinogenic effects. It is being explored for potential therapeutic applications in treating conditions such as depression and anxiety. 5-MeO-DMT is produced under GMP conditions, suitable for FDA-regulated clinical trials, and is synthetically produced and available as GLP material suitable for preclinical toxicology studies or as non-GMP research grade material.
- IUPAC Chemical Name:
5-Methoxy-2-(N,N-dimethylamino)ethylindole - Common Synonyms: 5-MeO-DMT, 5-Methoxy-N,N-dimethyltryptamine
- CAS Number: 1019-45-0
- DEA Schedule: Schedule I
- Controlled Substances Code Number (CSCN): 7431
rac-MDMA HCl
Racemic MDMA HCl, commonly known as Ecstasy, is a synthetic psychoactive drug with both stimulant and hallucinogenic properties. It acts primarily by increasing the release of serotonin, dopamine, and norepinephrine in the brain, resulting in heightened mood, energy, and perception. MDMA is being studied for its potential therapeutic applications in the treatment of PTSD and other psychiatric disorders. It is produced in a GMP-compliant manner, suitable for FDA-regulated clinical trials, and is available as GLP material for preclinical toxicology studies or as non-GMP research grade material.
- IUPAC Chemical Name:
(RS)-1-(benzo[d][1,3]dioxol-5-yl)-N-methylpropan-2-amine - Common Synonyms: MDMA, Ecstasy, XTC, Adam, 3,4-Methylenedioxymethamphetamine
- CAS Number: 42542-10-9
- DEA Schedule: Schedule I
- Controlled Substances Code Number (CSCN): 7405
Ibogaine HCl
Ibogaine is a naturally occurring psychoactive substance found in the root bark of the African shrub Tabernanthe iboga. It is known for its ability to reduce opioid withdrawal symptoms and cravings, making it a candidate for addiction treatment. Ibogaine interacts with various receptors, including NMDA, kappa-opioid, and nicotinic acetylcholine receptors, contributing to its complex pharmacological profile. It is produced under GMP conditions for FDA-regulated clinical trials and is available as GLP material for preclinical toxicology studies or as non-GMP research grade material.
- IUPAC Chemical Name:
(1R,15R,17S)-17-Methoxyibogamine - Common Synonyms:
Ibogaine, 12-Methoxyibogamine, Tabernanthine - CAS Number: 83-74-9
- DEA Schedule: Schedule I
- Controlled Substances Code Number (CSCN): 7260
Wish
to learn more?
Wish to learn more?
Take the next step towards unlocking your product's potential.
Let's embark on a journey of innovation and success together.
